YM-358 hydrate (potassium)
YM-358 hydrate potassium is an orally active angiotensin II type 1 (AT1) -receptor antagonist. YM-358 hydrate potassium can decrease cardiac volume overload. YM-358 hydrate potassium can be used for the research of cardiovascular disease, such as hypertension[1].
Product Specifications
CAS Number
161800-08-4
UNSPSC
12352005
Target
Angiotensin Receptor
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Smiles
CCC1=CN(N2N=C(N=C21)CC)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5.[K].O
Molecular Formula
C22H24KN8O
Molecular Weight
455.58
References & Citations
[1]Tokioka-Akagi T, et al. Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload. Jpn J Pharmacol. 2001 May;86 (1) :79-85.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
AT1 Receptor
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog